Inozyme Pharma Inc (INZY)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -31.987 | -43.119 | -51.93 | -38.664 | -51.048 | -41.859 |
| Return on Equity (%) | 100.382 | 83.764 | -90.362 | -42.356 | -58.913 | -54.984 |
| Return on Invested Capital (%) | 166.698 | 87.949 | -104.699 | -45.706 | -61.351 | -50.16 |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | -1.636 | -3.69 | 6.761 | 4.617 | 2.931 | 2.275 |
| Earnings Per Share | -0.821 | -2.191 | -2.413 | -2.392 | -1.66 | -1.152 |
| Cash Per Share | 4.24 | 3.511 | 1.199 | 0.985 | 0.815 | 0.56 |
| Working Capital Per Share | 4.819 | 4.913 | 6.03 | 4.382 | 2.888 | 2.94 |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | -0.821 | -2.191 | -2.413 | -2.392 | -1.66 | -1.152 |
| EBITDA Per Share | -0.821 | -2.191 | -2.413 | -2.392 | -1.66 | -1.152 |
| Free Cash Flow Per Share | -0.794 | -2.185 | -2.398 | -2.404 | -1.668 | -1.161 |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 8.48M | 9M | 23.39M | 23.67M | 40.39M | N/A |
| Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Shares Outstanding | 40.1M | 40.39M | 40.39M | 43.77M | 46.38M | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 391.19M |
| Price to Earnings Ratio | -5.46 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 11.23 |
| Price to Book Ratio | 2.77 |
| Dividend Yield | - |
| Shares Outstanding | 67.1M |
| Average Volume (1 week) | 280.1k |
| Average Volume (1 Month) | 249.6k |
| 52 Week Change | 35.68% |
| 52 Week High | 7.795 |
| 52 Week Low | 2.689 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
